Showing results (781-790 of 2,172) with videos related to
Sort By:
Pageof 218
Journal of Biopharmaceutical Statistics|December 31, 2019
Evaluation of surrogacy in the multi-trial setting based on information theory: an extension to ordinal outcomesHannah Ensor, Christopher J WeirJournal of Biopharmaceutical Statistics|December 12, 2019
A comparison of stochastic programming methods for portfolio level decision-makingEmily Graham, Thomas Jaki, Chris HarbronJournal of Biopharmaceutical Statistics|March 5, 2020
Bayesian joint modeling of ordinal longitudinal measurements and competing risks survival data for analysing Tehran Lipid and Glucose StudyTaban Baghfalaki, Shiva Kalantari, Mojtaba Ganjali, et al.Journal of Biopharmaceutical Statistics|January 3, 2019
Interim analysis of binary outcome data in clinical trials: a comparison of five estimatorsQing Shu Lu, Shein-Chung Chow, Siu-Keung TseJournal of Biopharmaceutical Statistics|December 11, 2019
Performance of randomization-based causal methods with and without integrating external data sources for adjusting overall survival in case of extensive treatment switches in placebo-controlled randomized oncology phase 3 trialsShogo Nomura, Tomohiro Shinozaki, Chikuma HamadaJournal of Biopharmaceutical Statistics|March 5, 2020
Functional modeling of pedaling kinematics for the Stroke patientsSounak Chakraborty, Tanujit Dey, Anish Mukherjee, et al.Journal of Biopharmaceutical Statistics|April 6, 2006
Sample size calculations based on generalized estimating equations for population pharmacokinetic experimentsKayode Ogungbenro, Leon Aarons, Gordon GrahamJournal of Biopharmaceutical Statistics|April 6, 2006
Multiple polyexponentials and quasipolynomials as empirical nonlinear regression models: a case study with HIV viral load dataL W Huson, J Chung, M SalgoJournal of Biopharmaceutical Statistics|April 6, 2006
Profile likelihood-based confidence intervals using Monte Carlo integration for population pharmacokinetic parametersTakashi Funatogawa, Ikuko Funatogawa, Akifumi YafuneJournal of Biopharmaceutical Statistics|October 8, 2004
Some statistical and regulatory issues in the evaluation of genetic and genomic testsGregory CampbellPageof 218